html5-img
1 / 29

PLANT POISONING

PLANT POISONING. Dr. Hisham Zein Alabdin. POISONOUS PLANTS. The active principles in most of these plants are alkaloids but glycosides ( digitales ) and resinous materials, as cannabis also exist.

sanaa
Download Presentation

PLANT POISONING

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. PLANT POISONING Dr. Hisham Zein Alabdin

  2. POISONOUS PLANTS • The active principles in most of these plants are alkaloids but glycosides (digitales) and resinous materials, as cannabis also exist. • The plant poisons have mainly remote action after their absorption. The route of poisoning is usually the oral one, so gastric lavage is indicated . each plant poison has its specific physiological antidote.

  3. Atropine poisoning Atropa belladonnas. Daturafastiosa, Daturastrammonium ( thorn apple), • Plant contains ; atropine, hyoscine and hyoscayamine. All parts of the plant contain the active substance. • Atropine has 2 actions: 1. central action causes stimulation of the CNS . In large toxic doses it causes depression. 2. peripheral action anticholenergic: atropine blocks nicotinic and muscarinic effects of acetycholine.

  4. Uses A- Therapeutic: • Pre- anesthetic. • Antispasmodics. • In the treatment of peptic ulcer. • Ophthalmic use. • Nocturnal enuresis • Toxicological use: as antidote in phosphate esters, digitalis, aconite poison. B- Non therapeutic: by addicts.

  5. Toxicokinetics • Absorption : slowly absorbed from the gut. • Metabolism: is in the liver and muscle to tropine tropic acid. • Excretion: is via the kidney in the urine, partly unchanged and partly metabolized.

  6. Pathophysiology A-Central action: stimulation followed by depression of CNS. Except hyoscine has depressant action only. B- Peripheral action: By blocking the muscarinic action of acetylcholine at the post ganglionic nerves whether parasympathetic or sympathetic (sweat glands)

  7. Clinical picture 1- Central effects: A- Stimulation phase: 1-Delirium ,disorientation, confusion, loss of short term memory, talkativeness(acute toxic psychosis). 2-Ataxia, in-coordination, hallucination(Lilliputian type) 3-Occupational purposeless movements (picking or grasping) 4- Tremors and convulsions.

  8. B- Depressant phase: it follows pre-existing stimulation phase . Patient is calm and falls into sleep then into stupor and coma. The respiration becomes slow and irregular. The end result will be central asphyxia and death.

  9. II- Peripheral effects: 1- Vital signs: • Increased respiration. • Increased blood pressure. • Increased temperature up to atropine fever resulting from anhydrosis. • Rapid pulse and may be cardiac arrhythmia.

  10. 2- Diminished secretion: • saliva dryness of the mouth with dysarthria and dysphagia. • Sweat dry skin • GIT constipation (decreased secretion and motility) • Urinary oliguria and retention of urine

  11. 3- Blood vessels: Peripheral vasodilatation to increase heat loss , leading to atropine flush which may be misdiagnosed as scarlet fever. 4-Eye changes: • Dilation and fixed pupils blurred vision. • Loss of accommodation due to cycloplegia (ciliary muscle paralysis) • Diplopia and photophobia • Loss of light reflex.

  12. The eye symptoms may be the earliest ones, thus the anticholinergic syndrome of parasympathetic paralysis can be remembered • Blind as a Bat. • Red as a Beet. • Dry as a Bone. • Hot as a Hare. • Mad as a Hen.

  13. Treatment • Support respiration. • Control convulsion if present by diazepam. • Stop further absorption by inducing emesis or by gastric lavage. • The physiological antidotes ( physostigmine, pilocarpine.). • Treat hyperthermia by ice packs • IV fluids to maintain urine output

  14. DIGITALIS (FOX GLOVE) Uses: • As cardiac tonic for cases of congestive heart failure. • As diuretic. • As an anti-arrhythmic especially in atrial flutter and. fibrillation as well as in paroxysmal tachycardia

  15. Toxicokinetics • Digitalis preparations are rapidly absorbed from the GIT and injection sites . Metabolism takes place in the liver . Excretion is via the renal route mainly, a small part in the bile ( enterohepatic circulation).

  16. Pathophysiology Digitalis toxicity is an exacerbation of the drug Pharmacological actions: • Positive inotropic action: it increases the force and velocity of myocardial contraction by increasing intracellular Ca++ . This increase in the excitability and contractility of the atria and ventricles may result in extrasystoles and tachyarrhythmias.

  17. Negative chronotropic action: (rate) It increases the vagal tone in the early stage leading to decreased heart rate. • Negative dromotropic action: (conduction velocity) It slows AV node conduction velocity that can be depressed resulting in Saor AV block. • It increases the refractory periods of AV node and depresses that of the atria and ventricles, resulting in prolonged PR interval , AV block and shortened QT interval. • Alteration of impulse formation with suppressant and excitatory effects.

  18. Mechanism of action: • Digitalis inhibit active transport of Na+ ,K+ across cell membranes by binding to the Na+ - K+ ATP ase , and inhibiting Na+ - K+ pumps . • The net result • Increase extracellular potassium • Increase intracellular sodium. • Increase intracellular calcium

  19. Predisposing factors • Patient factor: (old age, myocardial infarction, core pulmonale, renal failure.) • Electrolyte abnormalities: ( hypo and hyperkalemia, hypomagnesemia, hyper and hypocalcemia.) • Drug interaction: (diuretics, antibiotics, quinidine , reserpine.)

  20. Clinical picture • Asymptomatic period of several minutes to several hours follows a single oral toxic dose. The toxic effects include non cardiac and cardiac effects A- Non cardiac : • GIT: may be the first complaints. (nausea, vomiting, abduminal pain and diarrhea) • CNS: headache, trigeminal neuralgia, confusion, delirium, disorientation, drowsiness and hallucination.

  21. Visual transient amblyopia, diplopia, blurring, scotoma and abnormal colour vision including yellow halos (xanthopsia). • Endocrine : Gynecomastia. • Allergic : Urticaria.

  22. B- Cardiac: Early slow full pulse (vagus) , with hypotension, followed by any type of dysrhythmia (altration in cardiac rate and rhythm): • AV block. • Atrial tachycardia with AV block. • Sino-atrial block. • Atrial flutter, fibrillation. • Ventricular premature extrasystoles , flutter.

  23. Digoxin toxicity

  24. MANAGEMENT Investigations: 1-ECG: • Prolonged PR interval • Shortened QT interval • ST segment depression, inverted T wave. 2-Laboratory : • Electrolytes (K+ ) • Serum digoxin: toxic level is above 2ng/ml and is above 25ng/ml for digitoxin.

  25. Treatment • Stop drug administration. • monitor the patient in an ICU. • Establishment of respiration. • Dicontamination. • Atropine sulphate 1-2mg IM for bradycardia. • Phenytoin or diphenylhydantoin is the drug of choice for tachyarrhythmia. • Cholestyramine help excretion of digitalis

  26. Determine electrolytes hourly and correct electrolytes and acid base disturbances. • For hypokalaemia: potassium chloride5g in fruit juice every hour until ECG show improvement or peaking of T wave. • For hyperkalaemia : give 20 units of insulin with 5% Dextrose. • For hypocalcemia: avoid replacement because intracellular calcium is very high.

  27. Antidotal therapy: Digoxin specific antibody (Digibind).They bind to the free digoxin and increase the renal excretion of digoxin bound to FAB fragment. • Indications for (DIGIBIND ) • Hyperkalaemia (k + > 5 mEq/L). • Bradyarrhythmias unresponsive to atropine. • High degree AV block. • Life threatenting ventricular tachycardia and ventricular fibrillation.

  28. THANK YOU

More Related